This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the xenotransplantation program from United Therapeutics

Ticker(s): UTHR

Who's the expert?

Institution: Northwestern Medicine

  • Medical Director of the Translational Medicine Program & Professor of Medicine (Nephrology and Hypertension) and Surgery (Organ Transplantation) at Northwestern Medicine.
  • Sees 500 kidney transplant patients per year.
  • Research interests include the role of immunosuppressive medications in modulating the immune system, Genomic of chronic renal allograft rejection, Chronic kidney disease after liver transplant, and new immunosuppressive strategies.

Interview Questions
Q1.

Roughly how many kidney transplants do you conduct annually?

Added By: wilson_admin
Q2.

How strong is the unmet need for xenotransplantation in your opinion?

Added By: wilson_admin
Q3.

How convincing is United's xenotransplantation so far in your opinion?

Added By: wilson_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.